Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jul;115(6):1087–1095. doi: 10.1111/j.1476-5381.1995.tb15922.x

RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist.

S S Hegde 1, D W Bonhaus 1, L G Johnson 1, E Leung 1, R D Clark 1, R M Eglen 1
PMCID: PMC1908997  PMID: 7582507

Abstract

1. Selective antagonism of 5-HT4 receptors may provide therapeutic benefit in certain disorders of the myocardium, alimentary and lower urinary tract. We now report on RS 39604, a novel and selective 5-HT4 receptor antagonist and compare its pharmacological properties with those of SB 204070. 2. In guinea-pig striatal membranes, both RS 39604 and SB 204070 inhibited specific binding of [3H]-GR 113808 in a concentration-dependent manner yielding pKi estimates of 9.1 and 10.9, respectively. RS 39604 displayed a low affinity (pKi < 6.5) for 5-HT1A, 5-HT2C, 5-HT3, alpha 1c, D1, D2, M1, M2, AT1, B1 and opioid mu receptors and moderate affinity for sigma 1, (pKi = 6.8) and sigma 2 (pKi = 7.8) sites. 3. In the rat isolated oesophagus, precontracted with carbachol, RS 39604 (30-300 nM) behaved as a competitive antagonist towards 5-HT-induced relaxation (pA2 = 9.3; Schild slope = 1.0). We and others have shown previously that SB 204070 behaves as an unsurmountable antagonist in this preparation (pA2 approximately 10.5). In the guinea-pig isolated ileal mucosa, RS 39604 (30 nM) antagonized 5-MeOT-induced increase in short-circuit current (pA2 = 9.1). 4. In anaesthetized vagotomized micropigs, RS 39604, administered by the i.v. or intraduodenal (i.duod.) route, produced dose-dependent inhibition of 5-HT-induced tachycardia (ID50 = 4.7 micrograms kg-1, i.v. and 254.5 micrograms kg-1, i.duod). At maximal doses of 30 micrograms kg-1, i.v. and 6 mg kg-1, i.duod., the inhibitory effects of RS 39604 lasted for more than 6 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1090

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baxter G. S., Craig D. A., Clarke D. E. 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):439–446. doi: 10.1007/BF00169544. [DOI] [PubMed] [Google Scholar]
  2. Buchheit K. H., Gamse R., Pfannkuche H. J. SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol. 1991 Aug 6;200(2-3):373–374. doi: 10.1016/0014-2999(91)90601-l. [DOI] [PubMed] [Google Scholar]
  3. Budhoo M. R., Kellum J. M. The 5-HT4 receptor mediates 5-hydroxytryptamine-induced rise in short circuit current in the human jejunum in vitro. Surgery. 1994 Aug;116(2):396–400. [PubMed] [Google Scholar]
  4. Burleigh D. E., Borman R. A. Short-circuit current responses to 5-hydroxytryptamine in human ileal mucosa are mediated by a 5-HT4 receptor. Eur J Pharmacol. 1993 Sep 7;241(1):125–128. doi: 10.1016/0014-2999(93)90943-c. [DOI] [PubMed] [Google Scholar]
  5. Camilleri M., Prather C. M. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med. 1992 Jun 15;116(12 Pt 1):1001–1008. doi: 10.7326/0003-4819-116-12-1001. [DOI] [PubMed] [Google Scholar]
  6. Cooke H. J., Carey H. V. Pharmacological analysis of 5-hydroxytryptamine actions on guinea-pig ileal mucosa. Eur J Pharmacol. 1985 May 20;111(3):329–337. doi: 10.1016/0014-2999(85)90639-9. [DOI] [PubMed] [Google Scholar]
  7. Danzebrink R. M., Gebhart G. F. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res. 1991 Jan 4;538(1):64–75. doi: 10.1016/0006-8993(91)90377-8. [DOI] [PubMed] [Google Scholar]
  8. Dumuis A., Gozlan H., Sebben M., Ansanay H., Rizzi C. A., Turconi M., Monferini E., Giraldo E., Schiantarelli P., Ladinsky H. Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn Schmiedebergs Arch Pharmacol. 1992 Mar;345(3):264–269. doi: 10.1007/BF00168685. [DOI] [PubMed] [Google Scholar]
  9. Dumuis A., Sebben M., Bockaert J. The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):403–410. doi: 10.1007/BF00167041. [DOI] [PubMed] [Google Scholar]
  10. Eglen R. M., Bley K., Bonhaus D. W., Clark R. D., Hegde S. S., Johnson L. G., Leung E., Wong E. H. RS 23597-190: a potent and selective 5-HT4 receptor antagonist. Br J Pharmacol. 1993 Sep;110(1):119–126. doi: 10.1111/j.1476-5381.1993.tb13780.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elswood C. J., Bunce K. T., Humphrey P. P. Identification of putative 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol. 1991 Apr 17;196(2):149–155. doi: 10.1016/0014-2999(91)90421-l. [DOI] [PubMed] [Google Scholar]
  12. Feldman J. M. Carcinoid tumors and syndrome. Semin Oncol. 1987 Sep;14(3):237–246. [PubMed] [Google Scholar]
  13. Ford A. P., Clarke D. E. The 5-HT4 receptor. Med Res Rev. 1993 Nov;13(6):633–662. doi: 10.1002/med.2610130603. [DOI] [PubMed] [Google Scholar]
  14. Gale J. D., Grossman C. J., Whitehead J. W., Oxford A. W., Bunce K. T., Humphrey P. P. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol. 1994 Jan;111(1):332–338. doi: 10.1111/j.1476-5381.1994.tb14064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grossman C. J., Kilpatrick G. J., Bunce K. T. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol. 1993 Jul;109(3):618–624. doi: 10.1111/j.1476-5381.1993.tb13617.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hedge S. S., Moy T. M., Perry M. R., Loeb M., Eglen R. M. Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. J Pharmacol Exp Ther. 1994 Nov;271(2):741–747. [PubMed] [Google Scholar]
  17. Kaumann A. J., Sanders L. 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic beta-adrenoceptor blockade. Naunyn Schmiedebergs Arch Pharmacol. 1994 Apr;349(4):331–337. doi: 10.1007/BF00170877. [DOI] [PubMed] [Google Scholar]
  18. Lefebvre H., Contesse V., Delarue C., Soubrane C., Legrand A., Kuhn J. M., Wolf L. M., Vaudry H. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies. J Clin Endocrinol Metab. 1993 Dec;77(6):1662–1666. doi: 10.1210/jcem.77.6.8263156. [DOI] [PubMed] [Google Scholar]
  19. Ness T. J., Gebhart G. F. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res. 1988 May 31;450(1-2):153–169. doi: 10.1016/0006-8993(88)91555-7. [DOI] [PubMed] [Google Scholar]
  20. Parker R. B., Waud D. R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971 Apr;177(1):1–12. [PubMed] [Google Scholar]
  21. Scott C. M., Bunce K. T., Spraggs C. F. Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa. Br J Pharmacol. 1992 Aug;106(4):877–882. doi: 10.1111/j.1476-5381.1992.tb14428.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tam F. S., Hillier K., Bunce K. T. Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol. 1994 Sep;113(1):143–150. doi: 10.1111/j.1476-5381.1994.tb16186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tonini M., Messori E., Franceschetti G. P., Rizzi C. A., Castoldi A. F., Coccini T., Candura S. M. Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol. 1994 Sep;113(1):1–2. doi: 10.1111/j.1476-5381.1994.tb16163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Villalón C. M., den Boer M. O., Heiligers J. P., Saxena P. R. Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol. 1990 Aug;100(4):665–667. doi: 10.1111/j.1476-5381.1990.tb14073.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Walker J. M., Bowen W. D., Walker F. O., Matsumoto R. R., De Costa B., Rice K. C. Sigma receptors: biology and function. Pharmacol Rev. 1990 Dec;42(4):355–402. [PubMed] [Google Scholar]
  26. Wardle K. A., Ellis E. S., Baxter G. S., Kennett G. A., Gaster L. M., Sanger G. J. The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol. 1994 Jul;112(3):789–794. doi: 10.1111/j.1476-5381.1994.tb13148.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wong E. H., Bonhaus D. W., Wu I., Stefanich E., Eglen R. M. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197. J Neurochem. 1993 Mar;60(3):921–930. doi: 10.1111/j.1471-4159.1993.tb03238.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES